Global PVA Embolization Particles Market Size, Share & Trends Analysis Report, By Type (Conventional/Irregular PVA, and Compressible and Spherical PVA), By Application (Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization, and Trauma Embolization), Forecast (2022-2028)

The global PVA embolization particles market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Embolization is referred to as a procedure which is minimally invasive and involves the injection of an embolus to stop bleeding or to stop the flow of blood in to a tumor so as to minimize it for preparation of its removal. Various interventional radiology therapies use embolization. It is an alternative form of therapy for the patients whose tumors cannot be removed by surgery. In this procedure, an interventional radiologist uses image guidance to insert the catheter into a primary artery and advance it to vessel leading to a tumor or other part where the blood supply requires to be stopped. The global PVA embolization particles market growth is majorly attributable to the growing adoption of PVA embolization particles to treat hemorrhages, several types of cancerous tumors, as well as for the management of malignant hypertension caused by renal failure.

Some key players operating in the market include Merit Medical Systems, Inc., Cook Medical Inc., and Boston Scientific Corp., among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships and collaborations, new product launches and developments in the existing product portfolio, and so on. For instance, in 2017, Sirtex introduced SIR-Spheres Y-90 resin microspheres, which serves as first-line treatment for patients with liver metastases from right-sided primary colon cancer. In 2016, UK National Institute for Health and Care Excellence (NICE) issued a new update stating that National Health Service (NHS) doctors and commissioners may consider Sirtex’s SIR-Spheres Y-90 resin microspheres as an alternative to standard therapy with trans-arterial chemoembolization (TACE) or sorafenib in the treatment of patients with inoperable primary liver cancer.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Type
• By Application

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: Merit Medical Systems, Inc., Cook Medical Inc., and Boston Scientific Corp., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

 Global PVA Embolization Market Report by Segment

By Type

• Conventional/Irregular PVA
• Compressible and Spherical PVA

By Application

• Uterine Fibroid Embolization
• Prostatic Artery Embolization
• Liver Tumor Embolization
• Trauma Embolization

Global PVA Embolization Market Report by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa